Genetics Generation Advancement Corp. (4160.TWO)

TWD 70.2

(-2.9%)

Operating Income Summary of Genetics Generation Advancement Corp.

  • Genetics Generation Advancement Corp.'s latest annual operating income in 2023 was 18.57 Million TWD , up 1.38% from previous year.
  • Genetics Generation Advancement Corp.'s latest quarterly operating income in 2024 Q2 was 22.2 Million TWD , up 23.08% from previous quarter.
  • Genetics Generation Advancement Corp. reported an annual operating income of 34.01 Million TWD in 2022, up 231.53% from previous year.
  • Genetics Generation Advancement Corp. reported an annual operating income of 10.25 Million TWD in 2021, up 156.88% from previous year.
  • Genetics Generation Advancement Corp. reported a quarterly operating income of 18.04 Million TWD for 2024 Q1, up 106.73% from previous quarter.
  • Genetics Generation Advancement Corp. reported a quarterly operating income of 8.72 Million TWD for 2023 Q4, up 47.38% from previous quarter.

Annual Operating Income Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Operating Income of Genetics Generation Advancement Corp. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 18.57 Million TWD 1.38%
2022 34.01 Million TWD 231.53%
2021 10.25 Million TWD 156.88%
2020 -18.03 Million TWD -259.84%
2019 11.28 Million TWD 0.0%

Peer Operating Income Comparison of Genetics Generation Advancement Corp.

Name Operating Income Operating Income Difference
BIONET Corp. 84.69 Million TWD 78.067%
DIVA Laboratories, Ltd. 92.15 Million TWD 79.842%
Welgene Biotech Co.,Ltd. -4.25 Million TWD 536.159%
Puriblood Medical Co., Ltd. -50.4 Million TWD 136.855%
TFBS Bioscience Inc. -4.45 Million TWD 517.157%